Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pilot clinical trial on the efficacy of prophylactic use of vitamin K1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer.
Pinta F, Ponzetti A, Spadi R, Fanchini L, Zanini M, Mecca C, Sonetto C, Ciuffreda L, Racca P. Pinta F, et al. Among authors: spadi r. Clin Colorectal Cancer. 2014 Mar;13(1):62-7. doi: 10.1016/j.clcc.2013.10.001. Epub 2013 Nov 13. Clin Colorectal Cancer. 2014. PMID: 24332355 Clinical Trial.
Long-term survival after multidisciplinary management of a metastatic sarcomatoid porocarcinoma with repeated exeresis, radiotherapy, chemotherapy and cetuximab: case report and review of literature.
Ponzetti A, Ribero S, Caliendo V, Spadi R, Macripò G, Lista P. Ponzetti A, et al. Among authors: spadi r. G Ital Dermatol Venereol. 2017 Feb;152(1):66-70. doi: 10.23736/S0392-0488.16.04778-7. Epub 2014 Sep 18. G Ital Dermatol Venereol. 2017. PMID: 25236317 Review.
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
Loupakis F, Cremolini C, Masi G, Lonardi S, Zagonel V, Salvatore L, Cortesi E, Tomasello G, Ronzoni M, Spadi R, Zaniboni A, Tonini G, Buonadonna A, Amoroso D, Chiara S, Carlomagno C, Boni C, Allegrini G, Boni L, Falcone A. Loupakis F, et al. Among authors: spadi r. N Engl J Med. 2014 Oct 23;371(17):1609-18. doi: 10.1056/NEJMoa1403108. N Engl J Med. 2014. PMID: 25337750 Free article. Clinical Trial.
Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study.
Filippi AR, Badellino S, Ceccarelli M, Guarneri A, Franco P, Monagheddu C, Spadi R, Ragona R, Racca P, Ricardi U. Filippi AR, et al. Among authors: spadi r. Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):524-9. doi: 10.1016/j.ijrobp.2014.10.046. Epub 2014 Dec 24. Int J Radiat Oncol Biol Phys. 2015. PMID: 25542308
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P, Mistrangelo M, Arcadipane F, Munoz F, Sciacero P, Spadi R, Migliaccio F, Angelini V, Bombaci S, Rondi N, Numico G, Ragona R, Cassoni P, Morino M, Racca P, Ricardi U. Franco P, et al. Among authors: spadi r. Cancer Invest. 2015 Jul;33(6):259-66. doi: 10.3109/07357907.2015.1028586. Epub 2015 May 7. Cancer Invest. 2015. PMID: 25950188 Clinical Trial.
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
Leone F, Marino D, Cereda S, Filippi R, Belli C, Spadi R, Nasti G, Montano M, Amatu A, Aprile G, Cagnazzo C, Fasola G, Siena S, Ciuffreda L, Reni M, Aglietta M. Leone F, et al. Among authors: spadi r. Cancer. 2016 Feb 15;122(4):574-81. doi: 10.1002/cncr.29778. Epub 2015 Nov 5. Cancer. 2016. PMID: 26540314 Free article. Clinical Trial.
30 results